Futures for cytk stock today
WebOct 27, 2024 · CYTK stock plunged more than 6% on Oct. 26, however, after Bristol reported $5 million in third-quarter Camzyos sales, lagging expectations for $19 million. ... Take a Trial Today. Get instant ... WebView the latest Philip Morris International Inc. (PM) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Futures for cytk stock today
Did you know?
WebApr 6, 2024 · A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebApr 10, 2024 · 2. Markets Today: Stock Indexes Fall on Weakness in Tech Stocks. 3. Option Volatility And Earnings Report For April 10 - 14. 4. Despite a Potential Devon Energy Dividend Cut, Investors Short Its Puts for Income. 5. Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data.
WebApr 6, 2024 · Cytokinetics stock price target raised to $36 from $26 at Mizuho May. 11, 2024 at 6:50 a.m. ET by Tomi Kilgore Coronavirus The Future of Medicine Beckons. … WebMar 30, 2024 · 03/30 BlackBerry stock dips after earnings show issues in cybersecurity business 03/30 U.K. agrees to join Asia-Pacific trade pact in post-Brexit deal
WebApr 10, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 … WebFeb 28, 2024 · In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $1.18 per share for CYTK, compared to a broader Zacks Consensus Estimate of …
WebFeb 28, 2024 · This suggests that analysts have very recently bumped up their estimates for CYTK, giving the stock a Zacks Earnings ESP of +3.19% heading into earnings season. Cytokinetics, Incorporated Price ...
WebMar 31, 2024 · 0. 0. 0. In the last 3 months, 13 analysts have offered 12-month price targets for Cytokinetics. The company has an average price target of $58.46 with a high of $71.00 and a low of $48.00. Below ... take care 3WebApr 14, 2024 · Cytokinetics (CYTK) Mizuho Securities analyst Salim Syed maintained a Buy rating on Cytokinetics today and set a price target of $80.00 . The company’s shares … take care 10th anniversaryWebCYTK Stock 12 Months Forecast. $57.83. (53.35% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $57.83 with a high forecast of $80.00 and a low forecast of $42.00. The average price target represents a 53.35% change from the last price of $37.71. take care album cover posterWebMar 31, 2024 · Cytokinetics, Inc. (CYTK) stock is trading at $35.08 as of 3:32 PM on Friday, Mar 31, a rise of $0.87, or 2.53% from the previous closing price of $34.21. The stock has traded between $34.70 and $36.66 so far today. Volume today is above average. take care 2014WebWhere the stock market will trade today based on Dow Jones Industrial Average, S&P 500 and Nasdaq-100 futures and implied open premarket values. Commodities, … take care album tracklistWebOct 8, 2024 · CYTK stock plunged 42.1% on the stock market today to a five-month low, closing at 16. AMGN stock tumbled 6.8% to 240.09, slipping below its 200-day moving average. twisted neckWebCYTK Growth Metrics. The 3 year cash and equivalents growth rate now stands at 192.88%. Its 4 year net cashflow from operations growth rate is now at -380.62%. Its 3 year net … take care alternatives